All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
12/21/20	4/A	Statement of changes in beneficial ownership of securities	2
12/21/20	4	Statement of changes in beneficial ownership of securities	2
12/18/20	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents EX-99.1	14
12/17/20	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.	7
12/14/20	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	8
12/11/20	4	Statement of changes in beneficial ownership of securities	2
12/08/20	8-K	Current report filing Documents EX-99.1	6
12/07/20	8-K	Current report filing Documents EX-2.1 EX-4.1 EX-4.2 EX-10.1 EX-10.2 EX-99.1 EX-99.2 EX-99.3	173
11/18/20	4	Statement of changes in beneficial ownership of securities	2
11/05/20	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	48